Polymerase chain reaction in the staging of solid tumors

Cancer Journal

Volumn 8, Issue 2, 2002, Pages 135-143

  Davis, Eric G ^a   Chao, Celia ^a   McMasters, Kelly M ^a,b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Breast cancer; Cancer; Colorectal cancer; Melanoma; Polymerase chain reaction; Solid tumors

Indexed keywords

ALPHA2B INTERFERON; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; COMPLEMENTARY DNA; CYTOKERATIN 19; CYTOKERATIN 20; DNA; GLYCOPROTEIN GP 100; HMB 45 PROTEIN; MAMMAGLOBIN; MELANOMA ANTIGEN; MESSENGER RNA; MUCIN 1; PROTEIN; PROTEIN S 100; SCATTER FACTOR RECEPTOR; TRACER; TRASTUZUMAB; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; UNCLASSIFIED DRUG; TUMOR MARKER;

BONE MARROW; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; DNA FLANKING REGION; DNA SEQUENCE; DRUG MEGADOSE; GENE AMPLIFICATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MACROPHAGE; MARKER GENE; MELANOMA; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SOLID TUMOR; THORACOSCOPY; BREAST TUMOR; COLORECTAL TUMOR; GENETIC MARKER; GENETICS; METHODOLOGY; PATHOLOGY; SKIN TUMOR;

BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; GENETIC MARKERS; HUMANS; MELANOMA; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036517952     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200203000-00007     Document Type: Review

References (57)

1. Bailar JC III, Gornik HL. Cancer undefeated. N Engl J Med 1997;336:1569-1574.
2. Baumforth KRN, Nelson PN, Digby JE et al. Demystified . . . the polymerase chain reaction. BMJ 1999;52:1-10.
3. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
4. Mustafa IA, Cole B, Wanebo HJ et al. Prognostic analysis of survival in small breast cancers. J Am Coll Surg 1998;186:562-569.
5. Giuliano AE, Kirgan DM, Guenther JM et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
6. Simmons R, Hoda S, Osborne M. Bone marrow micrometastases in breast cancer patients. Am J Surg 2000;180:309-312.
7. Bostick PJ, Chatterjee S, Chi DD et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-2640.
8. Kahn HJ, Yang L-Y, Blondal J et al. RT-PCR amplification of CK-19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat 2000;60:143-151.
9. Hu XC, Chow LWC. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR). Eur J Surg Oncol 2000;26:530-535.
10. Lockett MA, Baron PL, O'Brien PH et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg 1998;187:9-16.
11. Min CJ, Tafra L, Verbanac KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 1998;58:4581-4584.
12. Kataoka A, Mori M, Sadanaga N et al. RT-PCR detection of breast cancer cells in sentinel lymph nodes. Int J Oncol 2000;16:1147-1152.
13. Mitas M, Mikhitarian K, Walters C et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162-171.
14. Weiss L, Orr FW, Honn KV. Interactions of cancer cells with the microvasculature during metastasis. FASEB J 1988;2:12-21.
15. Fidler IJ. Angiogenesis. Cancer J 2000;6[suppl 2]:S134-S141.
16. Diel IJ, Cote RJ. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. Cancer Treat Rev 2000;26:53-65.
17. Masuda N, Tamaki Y, Sakita I et al.Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res 2000;6:4176-4185.
18. O'Malley FP, Parkes R, Latta E et al. Comparison of HER2/neu status assessedby quantitative polymerase chain reaction and immunohistochemistry. Am J Clin Pathol 2001;115:504-511.
19. Mori M, Mimori K, Ueo H et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996;68:739-743.
20. Mori M, Mimori K, Inoue H et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-3420.
21. Jonas S, Windeatt S, O-Boateng A et al. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma byreverse transcriptase polymerase chain reaction. Gut 1996;39:717-721.
22. Bustin SA, Gyselman VG, Williams NS et al. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999;79:1813-1820.
23. Piva MG, Navaglia F, Basso D et al. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Oncology 2000;59:323-328.
24. Guadagni F, Kantor J, Aloe S et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analysis and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 2001;61:2523-2532.
25. Yamaguchi K, Takagi Y, Aoki S et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65.
26. Bessa X, Elizalde JI, Boix L et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001;120:1084-1092.
27. Wong IHN, Yeo W, Chan AT et al. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoemnoma: bryonic antigen level and tumor progression. Cancer Lett 2001;162:65-73.
28. Bernini A, Spencer M, Frizelle S. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes. Cancer Detect Prev 2000;24:72-79.
29. Mori M, Mimori K, Ueo H et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128-132.
30. Rosenberg R, Hoos A, Mueller J et al. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 2000;83:1323-1329.
31. Bilchik AJ, Saha S, Wiese D et al. Molecular staging of early colon cancer on the basis of sentinel lymph node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128-1136.
32. Merrie AEH, Phillips LV, Yun K et al. Skip metastases in colon cancer: assessment by lymph nodemapping usingmolecular detection. Surgery 2001;129:684-691.
33. Miyake Y, Fujiwara Y, Ohue M et al. Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. Int J Oncol 2000;16:289-293.
34. Liefers G-J, Cleton-Jansen A-M, van de Velde CJH et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-228.
35. Taback B, Morton DL, O'Day SJ et al. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Recent Results Cancer Res 2001;158:78-92.
36. Smith B, Selby P, Southgate J et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-1229.
37. Schwurzer-Voit M, Proebstle TM, Sterry W. Identification of lymph nodemetastases by use of polymerase chain reaction (PCR) in melanoma patients. Eur J Cancer 1996;32A:264-268.
38. Brossart P, Keilholz U, Willhauck M et al. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993;101:887-889.
39. Proebstle TM, Jiang W, Hogel J et al. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival, and other risk factors. Br J Cancer 2000;82:118-123.
40. van der Velde-Zimmerman D, Schipper MEI, de Weger RA et al. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol 2000;7:51-54.
41. Blaheta H-J, Schittek B, Breuninger H et al. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma. Recent Results Cancer Res 2001;158:137-146.
42. Shivers SC, Li W, Lin J et al. The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res 2001;158:187-199.
43. Bieligk SC, Ghossein R, Bhattacharya S et al. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999;6:232-240.
44. Sarantou T, Chi DDJ, Garrison DA et al.Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997;57:1371-1376.
45. Shivers S, Wang X, Li W et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-1415.
46. Hoon DSB, Bostick P, Kuo C et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 2000;60:2253-2257.
47. Wrightson WR, Wong SL, Edwards MJ et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy formelanoma. J Surg Res 2001;98:47-51.
48. McMasters KM, Sondak VK, Lotze MT et al. Recent advances in melanoma staging and therapy. Ann Surg Oncol 1999;6:467-475.
49. Kirkwood JM, Strawderman MH, Ernstoff MS et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneousmelanoma: the Eastern Cooperative Oncology Group EST 1684. J Clin Oncol 1996;14:7-17.
50. Kirkwood JM, Ibrahim JG, Sondak VK et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000;18:2444-2458.
51. Kirkwood JM, Ibrahim JG, Sosman JA et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/qs-21 vaccine in patients with resected stage IIb-III melanoma: results of Intergroup Trial E1694/S9512/C509801. J Clin Oncol 2000;19:2370-2380.
52. Kijima F, Natsugoe S, Takao S et al. Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 2000;58:38-44.
53. Luketich JD, Kassis ES, Shriver SP et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998;66:1715-1718.
54. Kassis ES, Nguyen N, Shriver SP et al. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. JSLS 1998;2:331-336.
55. Aihara T, Fujiwara Y, Miyake Y et al. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Lett 2000;150:79-84.
56. Van Trappen PO, Gyselman VG, Lowe DG et al. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. Lancet 2001;357:15-20.
57. Su SL, Boynton AL, Holmes EH et al. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. Semin Surg Oncol 2000;18:17-28.